中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
2期
43-44
,共2页
阿司匹林肠溶片%双嘧达莫%脑血栓
阿司匹林腸溶片%雙嘧達莫%腦血栓
아사필림장용편%쌍밀체막%뇌혈전
Aspirin Enteric-coated Tablets%DIPYRIDAMOLE%Cerebralthrombosis
目的探讨肠溶阿司匹林联合双嘧达莫治疗脑血栓的临床效果及安全性.方法将52例脑血栓患者随机分为观察组和对照组各26例,观察组给予肠溶阿司匹林联合双嘧达莫治疗,对照组仅给予肠溶阿司匹林治疗,比较两组患者的临床效果.结果观察组患者的总有效率为100%,对照组患者的总有效率为76.92%,观察组的治疗效果明显优于对照组,两组比较,差异具有统计学意义(P<0.05).结论肠溶阿司匹林联合双嘧达莫治疗脑血栓的临床效果显著,优于单独用药,能显著改善脑血栓的形成,改善患者神经功能,有利于患者早日康复,并且使用安全、方便,值得临床推广应用.
目的探討腸溶阿司匹林聯閤雙嘧達莫治療腦血栓的臨床效果及安全性.方法將52例腦血栓患者隨機分為觀察組和對照組各26例,觀察組給予腸溶阿司匹林聯閤雙嘧達莫治療,對照組僅給予腸溶阿司匹林治療,比較兩組患者的臨床效果.結果觀察組患者的總有效率為100%,對照組患者的總有效率為76.92%,觀察組的治療效果明顯優于對照組,兩組比較,差異具有統計學意義(P<0.05).結論腸溶阿司匹林聯閤雙嘧達莫治療腦血栓的臨床效果顯著,優于單獨用藥,能顯著改善腦血栓的形成,改善患者神經功能,有利于患者早日康複,併且使用安全、方便,值得臨床推廣應用.
목적탐토장용아사필림연합쌍밀체막치료뇌혈전적림상효과급안전성.방법장52례뇌혈전환자수궤분위관찰조화대조조각26례,관찰조급여장용아사필림연합쌍밀체막치료,대조조부급여장용아사필림치료,비교량조환자적림상효과.결과관찰조환자적총유효솔위100%,대조조환자적총유효솔위76.92%,관찰조적치료효과명현우우대조조,량조비교,차이구유통계학의의(P<0.05).결론장용아사필림연합쌍밀체막치료뇌혈전적림상효과현저,우우단독용약,능현저개선뇌혈전적형성,개선환자신경공능,유리우환자조일강복,병차사용안전、방편,치득림상추엄응용.
Objective Discuss Aspirin Enteric-coated Tablets combined DIPYRIDAMOLE treatment Cerebralthrombosis clinical effectiveness and safety. Methods Will Cerebralthrombosis 52 cases were randomly divided into observation group and control group all 26 cases, observation group was given Aspirin Enteric-coated Tablets combined DIPYRIDAMOLE treatment group, only give Aspirin Enteric-coated Tablets treatment, compared between the two groups patients clinical effect. Results The observation group patients total effective rate is 100%and patients in control group total effective rate is 76.92%and the therapeutic effect of observation group was better than control group, two groups of comparisons, a statistically significant difference(P<0.05). Conclusion Aspirin Enteric-coated Tablets combined DIPYRIDAMOLE the clinical effect of treatment of cerebral thrombosis significantly, which is higher than that of single use, can improve the Cerebralthrombosis formation,improve the patients nervous function, benefit to patients recover at an early date, and the use of safe, convenient,it is worth clinical application.